Skip to Content
주식/증권 📈 긍정적

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh

요약

Myriad Genetics trades near 0.4x sales as investors weigh cheap valuation against 2026 launch execution and uneven segment performance.